PIVONELLO, ROSARIO
 Distribuzione geografica
Continente #
AS - Asia 17.312
NA - Nord America 14.057
EU - Europa 10.879
SA - Sud America 2.200
AF - Africa 423
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 13
Totale 44.907
Nazione #
US - Stati Uniti d'America 13.427
SG - Singapore 7.764
RU - Federazione Russa 5.239
CN - Cina 3.366
VN - Vietnam 2.976
BR - Brasile 1.738
IT - Italia 1.500
HK - Hong Kong 1.469
DE - Germania 834
FR - Francia 607
FI - Finlandia 535
NL - Olanda 510
SE - Svezia 388
CA - Canada 345
IE - Irlanda 321
GB - Regno Unito 293
IN - India 283
UA - Ucraina 258
JP - Giappone 228
BD - Bangladesh 207
MX - Messico 177
AR - Argentina 170
KR - Corea 145
IQ - Iraq 125
TR - Turchia 106
CI - Costa d'Avorio 101
PL - Polonia 89
EC - Ecuador 87
ZA - Sudafrica 87
ID - Indonesia 86
PH - Filippine 84
ES - Italia 77
TH - Thailandia 68
CO - Colombia 53
PK - Pakistan 51
KE - Kenya 45
TW - Taiwan 43
AT - Austria 40
VE - Venezuela 36
UZ - Uzbekistan 33
EG - Egitto 32
CL - Cile 31
TN - Tunisia 31
JO - Giordania 30
MA - Marocco 30
PY - Paraguay 30
IL - Israele 28
SA - Arabia Saudita 28
LT - Lituania 27
IR - Iran 24
AE - Emirati Arabi Uniti 22
BE - Belgio 21
CZ - Repubblica Ceca 19
UY - Uruguay 19
DZ - Algeria 18
CR - Costa Rica 17
LB - Libano 17
PE - Perù 17
BO - Bolivia 16
PT - Portogallo 16
AU - Australia 15
JM - Giamaica 15
NP - Nepal 15
ET - Etiopia 14
AZ - Azerbaigian 13
HN - Honduras 13
RO - Romania 13
MY - Malesia 12
CH - Svizzera 11
OM - Oman 10
SY - Repubblica araba siriana 10
DO - Repubblica Dominicana 9
PA - Panama 9
TT - Trinidad e Tobago 9
LV - Lettonia 8
NI - Nicaragua 8
PS - Palestinian Territory 8
GR - Grecia 7
KZ - Kazakistan 7
NG - Nigeria 7
AF - Afghanistan, Repubblica islamica di 6
AL - Albania 6
HU - Ungheria 6
KW - Kuwait 6
SN - Senegal 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BB - Barbados 5
BG - Bulgaria 5
BH - Bahrain 5
BY - Bielorussia 5
HR - Croazia 5
KG - Kirghizistan 5
MD - Moldavia 5
SI - Slovenia 5
BF - Burkina Faso 4
BS - Bahamas 4
BW - Botswana 4
CG - Congo 4
CW - ???statistics.table.value.countryCode.CW??? 4
Totale 44.777
Città #
Singapore 3.721
San Jose 2.714
Hong Kong 1.435
Moscow 1.274
Chandler 1.124
Ashburn 967
Ho Chi Minh City 891
Beijing 859
Hanoi 621
Hefei 611
Santa Clara 535
Millbury 473
The Dalles 432
Amsterdam 426
Naples 400
Lauterbourg 391
Los Angeles 355
Princeton 303
Munich 283
Jacksonville 277
Nanjing 259
Buffalo 221
New York 212
Wilmington 198
Tokyo 196
Boston 170
São Paulo 159
Redondo Beach 149
Dallas 148
Napoli 138
Da Nang 131
Des Moines 124
Helsinki 120
Ottawa 120
Turku 116
Seoul 106
Haiphong 105
Orem 104
Frankfurt am Main 97
Houston 93
Woodbridge 84
Seattle 82
Montreal 81
Boardman 79
Lawrence 78
Nanchang 77
Chicago 74
Rome 74
Mexico City 72
Warsaw 72
Falkenstein 61
Toronto 59
Council Bluffs 58
Hebei 58
Atlanta 57
San Francisco 54
Chennai 53
Denver 53
Brooklyn 52
Nuremberg 52
Phoenix 52
Rio de Janeiro 52
London 50
Tianjin 49
Biên Hòa 48
Johannesburg 46
Stockholm 45
Hải Dương 43
Shenyang 43
Baghdad 42
Nairobi 42
Poplar 42
Manchester 40
Changsha 38
Ann Arbor 37
Can Tho 35
Curitiba 35
Milan 35
Norwalk 35
Jiaxing 33
Shanghai 33
Ankara 32
Brasília 32
Belo Horizonte 31
Kochi 31
Kronberg 31
Quito 30
Tashkent 30
Porto Alegre 29
Falls Church 28
New Delhi 28
Ninh Bình 28
Dhaka 27
San Mateo 27
Dublin 26
Guayaquil 26
Mumbai 25
Guangzhou 24
Thái Nguyên 24
Bologna 23
Totale 23.795
Nome #
Effects of Chrono-Exercise and Chrono-Nutrition on Muscle Health: Understanding the Molecular Mechanisms Activated by Timed Exercise and Consumption of Proteins and Carbohydrates 243
Medical consequences of acromegaly: what are the effects of biochemical control? 222
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 214
Spot-light on microbiota in obesity and cancer 212
Exposure to artificial light at night: A common link for obesity and cancer? 187
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 180
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 179
The role of vitamin D in male fertility: A focus on the testis 178
Effect of the acute administration of the Dopamine Agonist Cabergoline on glucose tolerance and Insuline Sensitivity in patient with obesity. 176
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 172
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 169
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 169
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 169
Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months. 164
Association between vitamin D and sperm parameters: Clinical evidence 162
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma 161
Flavor perception test: evaluation in patients with Kallmann syndrome 161
Bisphenol A: An emerging threat to female fertility 160
Correlation between Morphometric parameters and chromatin fragmentation in spermatozoa of Canis familiaris. 158
Circulating myomiRNAs as biomarkers in patients with Cushing's syndrome 157
Long-term high-dose l-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial 157
Reduced bone mineral density in glycogen storage disease type III: Evidence for a possible connection between metabolic imbalance and bone homeostasis 156
Selenium supplementation modulates apoptotic processes in thyroid follicular cells 156
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). 156
Cardiovascular consequences of early-onset growth hormone excess 155
Neuropsychiatric disorders in Cushing's syndrome. 154
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 153
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 153
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 153
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 152
Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study 152
1,25‑Dihydroxyvitamin D3 mitigates the adipogenesis induced by bisphenol A in 3T3-L1 and hAMSC through miR-27-3p regulation 149
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study 149
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. 149
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 149
Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas 149
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 149
The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review 149
Hypertension in acromegaly and in the normal population: prevalence and determinants 148
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome 148
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma 148
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 147
Air pollution and female fertility: A systematic review of literature 145
Severe systemic complications of acromegaly 144
The environment and male reproduction: The effect of cadmium exposure on reproductive functions and its implication in fertility 143
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 143
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center. 143
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly 142
Acromegaly and the cardiovascular system 142
Pathophysiology of diabetes mellitus in Cushing's syndrome. 142
The effect of FT500 Plus® on ovarian stimulation in PCOS women 142
Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. 141
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 141
Shedding new light on female fertility: The role of vitamin D 141
Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature 140
High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study 140
CORTISOL CIRCADIAN RHYTHM AND INSULIN RESISTANCE IN MUSCLE: EFFECT OF DOSING AND TIMING OF HYDROCORTISONE EXPOSURE ON INSULIN SENSITIVITY IN SYNCHRONIZED MUSCLE CELLS 140
New perspectives in the medical treatment of acromegaly 139
Cardiac effect of thyrotoxicosis in acromegaly 139
Cushing's syndrome: aftermath of the cure. 139
Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit 139
Impact of Somatostatin Analogs vs. Surgery on glucose metabolism in acromegaly: Results of a 5 years observational, open, prospective study 138
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 138
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 138
Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center (Endocrine, (2015), 50, (725-740) DOI 10.1007/s12020-015-0557-2) 138
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials 138
Adverse events associated with somatostatin analogs in acromegaly. 137
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 137
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 137
The Treatment of Cushing's Disease. 136
17 beta hyrossisteroid dehydrogenase type 3 deficiency : a new case of a rare disease with uncommon gene mutation 136
Fertility in Acromegaly: a single center experience on female patients during active disease and after disease remission 135
Acromegalic axial arthropathy: a clinical case-control study 135
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studies. 135
The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology 135
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system. 134
Evaluation of morphometric parameters and chromatin integrity in the sperm of stallion food supplemented with Maca. 134
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. 133
Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas 132
[Chronic kidney disease: fertility and sexuality] 132
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 131
Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment 131
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure 131
Effect of Cabergoline on Metabolism in Prolactinomas. 131
Metabolic alterations and cardiovascular outcomes of cortisol excess 131
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life 131
The role of somatostatin analogs in the management of hepatocellular carcinoma 130
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 130
CONVENTIONAL AND NUCLEAR MEDICINE IMAGING IN ECTOPIC CUSHING'S SYNDROME: A SYSTEMATIC REVIEW. 129
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 129
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 129
The role of dopamine pathway on human sperm: in vitro effect of dopamine receptor agonists and antagonists on sperm motility, kinetics and viability 129
Vitamin D Reverts the Exosome-Mediated Transfer of Cancer Resistance to the mTOR Inhibitor Everolimus in Hepatocellular Carcinoma 129
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission 128
The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas 128
Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. 128
Imbalanced cortisol concentrations in glycogen storage disease type I: Evidence for a possible link between endocrine regulation and metabolic derangement 128
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial. 127
The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. 126
Cardiovascular alterations in adult GH deficiency 126
Totale 14.769
Categoria #
all - tutte 145.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 0 0 33
2021/20222.214 37 7 10 25 54 215 29 61 372 120 376 908
2022/20232.709 409 227 75 213 329 262 27 230 374 414 112 37
2023/20241.766 86 271 239 142 80 115 49 190 26 36 313 219
2024/202511.809 632 758 99 95 252 584 1.326 761 859 1.053 4.298 1.092
2025/202623.679 2.578 1.855 2.431 2.103 4.015 917 2.936 1.403 3.107 1.399 736 199
Totale 45.550